Skip to content
Her Choice

Restricting Mifepristone Access Could Empower Abusers

The 5th U.S. Circuit Court of Appeals heard arguments on Sept. 9 in Louisiana v. FDA, one of three cases threatening nationwide access to mifepristone, the medication used in the majority of abortions in the United States.

Restricting Mifepristone Access Could Empower Abusers

Need Support?

Find verified resources for reproductive healthcare, support services, and advocacy organizations.

Find Resources